Swissmedic

14 articles about Swissmedic

• Swissmedic Authorizes COVID-19 Vaccine Moderna for Use in Switzerland

  1/12/2021

  Swiss Federal Government has secured 7.5 million doses and first deliveries expected to begin in January

• Swissmedic Approves Carbetocin Ferring for the Prevention of Postpartum Haemorrhage in All Births

  5/13/2020

  Excessive bleeding after birth, also known as postpartum haemorrhage (PPH), is the leading direct cause of maternal mortality worldwide,1 causing approximately 70,000 deaths each year1 – 99% of which occur in low- and lower-middle income countries2

• Vivior’s System Cleared for CE Mark – Market Introduction This Year in Europe

  3/26/2019

  Vivior has cleared their system as a Class I medical device and is planning the market introduction later this year in Switzerland and the European Union.

• CORRECTION - Sidley Austin LLP: Former Swissmedic Head of Legal Affairs Andreas Balsiger Betts to Join Sidley in Switzerland

  12/6/2018

  Andreas Balsiger Betts joins along with Olivier Goarnisson to expand the firm's capabilities and establish the first global life sciences practice serving all language areas of Switzerland

• Former Swissmedic Head of Legal Affairs Andreas Balsiger Betts to Join Sidley in Switzerland

  12/6/2018

  Andreas Balsiger Betts joins along with Olivier Goarnisson to expand the firm's capabilities and establish the first global life sciences practice serving all language areas of Switzerland

• Swissmedic Approves Akynzeo (netupitant/palonosetron) For Use In The Prevention Of Chemotherapy Induced Nausea And Vomiting (CINV) In Switzerland

  12/15/2015

• Swissmedic Accepts For Review CSL Behring's MAA For rIX-FP For Patients With Hemophilia B

  7/28/2015

• Newron Pharmaceuticals Release: Safinamide Application For Authorization Submitted To Swissmedic

  4/7/2014

• Swissmedic Accepts for Review Basilea Pharmaceutica's Ceftobiprole Marketing Authorization Application for the Treatment of Pneumonia

  9/16/2013

• Osiris Therapeutics, Inc. Release: Swissmedic Invokes Rapid Authorization Procedures for Prochymal Review

  9/28/2012

• Apricus Biosciences Submits Response to Swissmedic for Its Vitaros(R) Market Application for Erectile Dysfunction

  6/14/2012

• Celgene International Sárl's REVLIMID(R) Granted Swissmedic Approval for Treatment of Rare Blood Cancer

  11/23/2011

• Swissmedic Grants Approval for a Clinical Study of Neovacs SA's TNFa-kinoid Candidate for the Treatment of Crohn's Disease

  6/2/2009

• Manhattan Pharmaceuticals, Inc. Receives Swissmedic's Approval To Commence Phase IIa Trial With OE, Its Oral Obesity Drug Candidate

  5/16/2006